Showing results (231-240 of 445) with videos related to

Sort By:
Pageof 45
Journal of Interventional Cardiology|September 20, 2012
Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stentsWayne B Batchelor, Stephen G Ellis, John A Ormiston, et al.
The Journal of Craniofacial Surgery|August 14, 2025
Facial Feminization: Surgical Trends and Outcomes From a Single InstitutionSydney Somers, Tamara Osborn, Serin Springer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2009
Very late changes in the dilated lesion following coronary balloon angioplasty: a 17 year serial quantitative angiographic studyRobert I Hatrick, John A Ormiston, Peter N Ruygrok, et al.
European Heart Journal. Case Reports|May 27, 2022
May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case seriesCameron K Ormiston, Erika Padilla, David T Van, et al.
The American Journal of Cardiology|January 15, 2016
Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies)Alexandra J Lansky, Adnan Kastrati, Elazer R Edelman, et al.
JACC. Cardiovascular Interventions|October 26, 2013
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trialYoshinobu Onuma, Dariusz Dudek, Leif Thuesen, et al.
Plastic and Reconstructive Surgery. Global Open|November 16, 2022
A Custom Stabilizing Splint for the Management of BLCP with Protruding PremaxillaKaylee Scott, Jack D Sudduth, Laurel Ormiston, et al.
Metabolites|September 23, 2022
Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given ChemotherapyAustin Angelotti, Deena B Snoke, Kate Ormiston, et al.
The American Journal of Cardiology|November 21, 2007
Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human studyIan T Meredith, John Ormiston, Robert Whitbourn, et al.
Journal of the American College of Cardiology|January 1, 1995
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapyH D White, J K French, A W Hamer, et al.
Pageof 45